CHLORAPREP WITH TINT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chloraprep With Tint, and when can generic versions of Chloraprep With Tint launch?
Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-two patent family members in twelve countries.
The generic ingredient in CHLORAPREP WITH TINT is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
DrugPatentWatch® Generic Entry Outlook for Chloraprep With Tint
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLORAPREP WITH TINT?
- What are the global sales for CHLORAPREP WITH TINT?
- What is Average Wholesale Price for CHLORAPREP WITH TINT?
Summary for CHLORAPREP WITH TINT
| International Patents: | 22 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 45 |
| DailyMed Link: | CHLORAPREP WITH TINT at DailyMed |
Recent Clinical Trials for CHLORAPREP WITH TINT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yaneve Fonge | Phase 4 |
| Rush University Medical Center | N/A |
| Gebauer Company | Phase 4 |
Pharmacology for CHLORAPREP WITH TINT
| Physiological Effect | Decreased Cell Wall Integrity |
US Patents and Regulatory Information for CHLORAPREP WITH TINT
CHLORAPREP WITH TINT is protected by two US patents.
Patents protecting CHLORAPREP WITH TINT
Liquid applicator with a mechanism for fracturing multiple ampoules
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicator for coloring antiseptic
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE AS AN ANTISEPTIC FOR THE PREPARATION OF A PATIENT'S SKIN PRIOR TO SURGERY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Becton Dickinson Co | CHLORAPREP WITH TINT | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-002 | May 3, 2005 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Becton Dickinson Co | CHLORAPREP WITH TINT | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-007 | Oct 10, 2006 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Becton Dickinson Co | CHLORAPREP WITH TINT | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-002 | May 3, 2005 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Becton Dickinson Co | CHLORAPREP WITH TINT | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-005 | Apr 3, 2006 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CHLORAPREP WITH TINT
International Patents for CHLORAPREP WITH TINT
See the table below for patents covering CHLORAPREP WITH TINT around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Germany | 60325094 | ⤷ Sign Up | |
| Spain | 2159651 | ⤷ Sign Up | |
| New Zealand | 525518 | Liquid applicator with diametrically opposed wings | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 0246089 | ⤷ Sign Up | |
| Japan | 2000507478 | ⤷ Sign Up | |
| Spain | 2230615 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
